Cerecor Inc. Reports Third Quarter 2016 Financial Results

Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders, today announced its financial results for the third quarter ended September 30, 2016.

This entry was posted in Recent Development News: Q4 - 2016, Recent Developments. Bookmark the permalink.
Read Full Article »